Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil vs fentanyl for postoperative ICU analgesia
CTR20221670Phase 3Completed
- Sponsor
- Jiangsu Nhwa Pharmaceutical
- Start
- Jul 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of remifentanil in postoperative pain, sponsored by Jiangsu Nhwa Pharmaceutical. Started Jul 2022; status: completed.
02
Drugs
remifentanil
03
Conditions
postoperative pain
Beyond the preview
Go deeper on CTR20221670.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20221670.